Company: CSCIF
Filing Date: 2025-04-09
Form Type: 20-F
Source: 0001641172-25-003456
Chunk: 87

Company: COSCIENS Biopharma Inc.
Filing Date: 2025-04-09
Form: 20-F
Item: Item 6
Chunk 87
---
In addition to the Board of directors of Ceapro, she currently sits on the Board of directors of the Quebec CPA Order. Previously, she
served as a Board member and executive of BioQuebec and as a Board member of Oxfam Quebec. In 2023, Ms. Foster completed the Directors
Education Program offered by the Institute of Corporate Directors - Rotman University and she holds the ICD. D designation.

Gilles Gagnonserves as the President and
Chief Executive Officer of COSCIENS. Prior to joining COSCIENS, he was President and CEO of Ceapro, a TSX-V-listed biopharmaceutical
company. During the past 40 years, Mr. Gagnon has worked at several management levels within the field of health, especially in the hospital
environment and pharmaceutical industry. Before going to Ceapro in 1999, Mr. Gagnon was Vice President, external affairs for Novartis
Pharma Canada Inc. from 1996 to 1999. Prior to that, from 1989 to 1996, Mr. Gagnon held various positions including Executive Director,
Corporate Planning and Business Development, Senior Director, Strategic Alliances, General Manager, Government Affairs and Access to
Market and Director of Professional Services at Sandoz Pharmaceuticals Inc. Throughout his career in the pharmaceutical industry, Mr.
Gagnon was especially involved in corporate development, alliance management, as well as marketing functions where he participated in
the launch of nine innovative pharmaceutical products in addition to his general management functions. Mr. Gagnon has participated in
several international committees and strategic advisory boards. He completed three mandates on the board of directors of Canada’s Research-Based
Pharmaceutical Companies (Rx& D, now Innovative Medicine Canada) where he represented for nine years members from the biopharmaceutical
sector and pioneered the Rx& D’s Canadian bio partnering initiative. He also served on various boards in the life sciences industry
including private organizations like Bio Quebec (Chairman) and Montreal In Vivo as well as publicly-traded biotech Nasdaq listed companies.
Mr. Gagnon holds a master’s degree in pharmacology (M. Sc.) and a master’s degree in Business Administration (MBA) from Sherbrooke
University, a certificate in General Management from the London Business School, UK and holds an ICD. D certification for completing the
Directors Education Program at the Rotman School of Management of University of Toronto. He is a member of